Vor Biopharma Inc.
VOR
$0.2235
-$0.0003-0.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -118.60M | -116.91M | -112.46M | -118.09M | -120.23M |
| Total Depreciation and Amortization | 3.41M | 3.53M | 3.56M | 3.60M | 3.60M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.44M | 13.72M | 12.88M | 12.48M | 12.94M |
| Change in Net Operating Assets | 1.49M | 5.00K | -3.59M | -2.22M | -2.79M |
| Cash from Operations | -100.26M | -99.66M | -99.62M | -104.24M | -106.49M |
| Capital Expenditure | -346.00K | -229.00K | -268.00K | -699.00K | -1.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.00M | 97.09M | 107.53M | 148.53M | 109.57M |
| Cash from Investing | 52.65M | 96.86M | 107.26M | 147.83M | 108.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 55.77M | 56.05M | 456.00K | 741.00K | 1.48M |
| Repurchase of Common Stock | -206.00K | -333.00K | -325.00K | -475.00K | -969.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.88M | -2.33M | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 52.69M | 53.39M | 131.00K | 266.00K | 515.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.08M | 50.59M | 7.77M | 43.86M | 2.51M |